Sunflower Pharmaceutical announced that the company previously decided to use no more than 2 billion yuan of idle funds for cash management, which is valid for 12 months. Recently, the company used 500 million yuan to purchase wealth management products, of which 200 million yuan purchased the China Merchants Bank Juyi Shengjin Series B financial management plan, and 300 million yuan purchased CNBC Wealth Management Anying Xiang's No. 47 wealth management product with a fixed income and steady two-month holding period. As of the announcement date, the unexpired amount of the company's cash management was 168 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.